| Name | Title | Contact Details |
|---|---|---|
Wayne Kubick |
Chief Technology Officer | Profile |
Loretto is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
iCardiac Technologies is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Rochester, NY. To find more information about iCardiac Technologies, please visit www.icardiac.com
Perfect Health, an independent privately held company based in Cambridge, MA, is a full service primary care practice that sees seniors in their own homes.
Alliance Physical Therapy Partners is the 7th largest physical therapy provider in the U.S., with more than 70 outpatient PT locations nationwide. The company was founded by patient-focused healthcare experts who were seeking to transform the traditional healthcare experience by infusing innovation and passion so that more people can enjoy the benefits of physical therapy. Alliance Physical Therapy Partners is also the parent company of Work-Fit, an injury prevention solutions provider who applies sports medicine techniques in the workplace to prevent injuries. In addition, BioCorrect Custom Orthotics Lab is part of the Alliance Physical Therapy Partner brands, providing a patented foot alignment system, evaluation process, and innovative custom and semi-custom foot orthotics for competitive athletics, outdoor recreation or people just living life to the fullest. Alliance Physical Therapy Partners is an affiliate of GPB Capital Holdings, LLC focused on acquiring private physical therapy practices across the U.S. to provide practice owners the opportunity to expand their footprint while receiving operational guidance and financial support. The Alliance team includes former private practice owners, direct marketing professionals and operations experts who have experience running and growing successful healthcare organizations. About GPB Capital Holdings, LLC GPB Capital is a New York-based alternative asset management firm focusing on acquiring income-producing private companies. GPB Capital seeks to provide its portfolio companies with the strategic planning, managerial insight, and capital needed to enable strong businesses to achieve the next level of growth and profitability. GPB Capital has over $1.5 billion in assets under management[i] and has acquired or invested in more than 160 portfolio companies. For more information, please visit www.gpb-cap.com. [i] Which is different and distinct from GPB Capital`s “Regulatory AUM.”
Kerr Drug recognizes that, for most of our customers, convenient access to products and services is a critical issue. That is why we go the extra mile to insure that our customers have the largest selection of things they need - everyday.